Flora Growth Corp. has entered into a binding Letter of Intent to acquire TruHC pharma GmbH

Flora Growth Corp. (FLGC), the Canada based global cannabis focused consumer-packaged goods company and pharmaceutical distributor, has agreed to acquire TruHC Pharma GmbH, the Germany based cannabis company, that holds a GDP wholesale and an EU-GMP processing and production license for medical cannabis, in an all-stock deal in exchange for 2,770,562 Flora common shares, valued at USD 6.4m based on the closing price of the Flora Growth shares on March 28, 2024 of USD 2.31 per share.

CapMan Buyout exits Havator to BMS Stangeland

BMS Stangeland AS, the Denmark based joint venture owned by the Danish–Norwegian crane operator BMS Group AS and Stangeland Gruppen …

Read More →

GRO Capital AS acquires DigitalRoute

Gro Capital AS (fka DKA Capital AS), the Denmark based private equity firm, has acquired Digital Route AB, the Sweden …

Read More →

Hasko becomes new majority owner in Sport Design Sweden AB

Hasko Invest AB, the Sweden based investment company, has acquired a majority stake in Sport Design Sweden AB, the Sweden …

Read More →

KKR to acquire Immedica Pharma

Kohlberg Kravis Roberts & Co (KKR), the US based global private equity firm, via its KKR Health Care Strategic Growth …

Read More →

IK Investment Partners acquires a minority stake in A-SAFE

IK Investment Partners Limited, the UK based private equity firm, has acquired a minority stake in A-SAFE, the UK based …

Read More →

DNV becomes the sole owner of Ocean Ecology

DNV AS, the Norway based assurance and risk management provider, has become the sole owner of Ocean Ecology, the UK …

Read More →
close-link
close-link